12:00 AM
 | 
Dec 07, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Velaglucerase alfa regulatory update

Shire submitted an MAA to EMEA for velaglucerase alfa to treat Type 1 Gaucher's disease. The agency's CHMP accepted the...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >